{"schema_version":"secwatch.filing_event.v1","accession":"0001613103-21-000070","form_type":"8-K","ticker":"MDT","cik":"0001613103","company_name":"Medtronic plc","filed_at":"2021-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.320721+00:00","generated_at":"2026-06-28T00:32:35.799577+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Chief Medical & Scientific Officer Richard Kuntz to retire April 29, 2022","bullets":["Richard Kuntz notified Medtronic on Dec 14, 2021 of retirement effective April 29, 2022.","Kuntz served as SVP and Chief Medical & Scientific Officer and on executive committee since 2005.","He leaves after over 15-year tenure at Medtronic and 40-year career as interventional cardiologist.","Filing does not name a successor or interim replacement for the role."],"urls":{"canonical":"https://secwatch.observer/filing/0001613103-21-000070","json":"https://secwatch.observer/filing/0001613103-21-000070.json","markdown":"https://secwatch.observer/filing/0001613103-21-000070.md","text":"https://secwatch.observer/filing/0001613103-21-000070.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1613103/000161310321000070/0001613103-21-000070-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1613103/000161310321000070/mdt-20211214.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T00:32:35.799577+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1c6eeecada","claim":"Richard Kuntz retired as Senior Vice President and Chief Medical and Scientific Officer at Medtronic plc.","evidence_excerpt":"On December 14, 2021, Richard Kuntz, M.D. notified Medtronic plc (the “Company”) that he had decided to retire as Senior Vice President and Chief Medical and Scientific Officer of the Company, effective as of April 29, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1613103/000161310321000070/0001613103-21-000070-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Senior Vice President and Chief Medical and Scientific Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}